tiprankstipranks
Trending News
More News >
Cytokinetics (CYTK)
:CYTK
US Market
Advertisement

Cytokinetics (CYTK) Technical Analysis

Compare
1,129 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Cytokinetics’s (CYTK) Moving Averages Convergence Divergence (MACD) indicator is 2.60, suggesting Cytokinetics is a Sell.
Cytokinetics’s (CYTK) 20-Day exponential moving average is 40.33, while Cytokinetics’s (CYTK) share price is $49.75, making it a Buy.
Cytokinetics’s (CYTK) 50-Day exponential moving average is 37.96, while Cytokinetics’s (CYTK) share price is $49.75, making it a Buy.

Cytokinetics (CYTK) Pivot Points

Sep 06, 2025, 10:50 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
46.34
47.10
48.54
49.30
50.74
51.50
52.94
Fibonacci
47.10
47.94
48.46
49.30
50.14
50.66
51.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cytokinetics (CYTK) Moving Averages

Sep 06, 2025, 10:50 PM
Period
Simple
Exponential
MA5
44.41Buy
45.97Buy
MA10
41.15Buy
42.87Buy
MA20
38.84Buy
40.33Buy
MA50
37.20Buy
37.96Buy
MA100
35.82Buy
38.02Buy
MA200
41.16Buy
42.31Buy
Cytokinetics’s (CYTK) 10-Day exponential moving average is 42.87, while Cytokinetics’s (CYTK) share price is $49.75, making it a Buy.
Cytokinetics’s (CYTK) 100-Day exponential moving average is 38.02, while Cytokinetics’s (CYTK) share price is $49.75, making it a Buy.
Cytokinetics’s (CYTK) stock price is $49.75 and Cytokinetics’s (CYTK) 50-day simple moving average is 37.20, creating a Buy signal.
Cytokinetics’s (CYTK) stock price is $49.75 and Cytokinetics’s (CYTK) 100-day simple moving average is 35.82, creating a Buy signal.
Cytokinetics’s (CYTK) stock price is $49.75 and Cytokinetics’s (CYTK) 200-day simple moving average is 41.16, creating a Buy signal.

Cytokinetics (CYTK) Technical Indicators

Sep 06, 2025, 10:50 PM
Name
Value
Implied Action
RSI (14)
74.54
Sell
STOCH (9,6)
94.23
Sell
STOCHRSI (14)
94.28
Sell
MACD (12,26)
2.60
Sell
ADX (14)
32.29
Neutral
Williams %R
-11.78
Sell
CCI (14)
241.05
Sell
ATR (14)
2.68
-
Ultimate Oscillator
62.47
Neutral
ROC
28.49
Buy
Cytokinetics’s (CYTK) Relative Strength Index (RSI) is 74.54, creating a Sell signal.
Cytokinetics’s (CYTK) Trend Strength Indicator (ADX) is 32.29, creating a Neutral signal.
Cytokinetics’s (CYTK) Commodity Channel Index (CCI) is 241.05, creating a Sell signal.
Cytokinetics’s (CYTK) Price Rate of Change (ROC) is 28.49, creating a Buy signal.

FAQ

Is CYTK a Buy, Hold, or Sell?
Based on CYTK’s technical indicators, CYTK is a Buy.
    What is CYTK’s RSI (14)?
    CYTK’s RSI (14) is 74.54, which suggests CYTK is a Sell.
      What is CYTK’s MACD?
      CYTK’s MACD is 2.60, which suggests CYTK is a Sell.
        What is CYTK’s 5-day moving average?
        CYTK’s 5-day moving average is 44.41, which suggests CYTK is a Buy.
          What is CYTK’s 20-day moving average?
          CYTK 20-day moving average is 38.84, which suggests CYTK is a Buy.
            What is CYTK’s 50-day moving average?
            CYTK’s 50-day moving average is 37.20, which suggests CYTK is a Buy.
              What is CYTK’s 200-day moving average?
              CYTK’s 200-day moving average is 41.16, which suggests CYTK is a Buy.
                What is CYTK’s Williams % R (14)?
                CYTK’s Williams % R (14) is -11.78, which suggests CYTK is a Sell.
                  What is CYTK’s CCI (14)?
                  CYTK’s CCI (14) is 241.05, which suggests CYTK is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis